Test using your wellness care professional if any of the next side effects continue or are bothersome or if you have any questions about them:
butabarbital will minimize the level or effect of nisoldipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
Dosage adjustment for concomitant therapy: Sizeable drug interactions exist, necessitating dose/frequency adjustment or avoidance. Seek advice from drug interactions databases To learn more.
butabarbital will reduce the extent or effect of estradiol vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
butabarbital will decrease the level or outcome of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
butabarbital will lower the extent or impact of fosaprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
butabarbital will lower the level or result of nilotinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
butabarbital will reduce the extent or outcome of levoketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
butabarbital will lower the level or outcome of vincristine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown.
The following adverse drug reactions and incidences are derived from products labeling Butabarbital for sale Until in any other case specified.
Teniposide: Barbiturates might lower the serum concentration of Teniposide. Management: Contemplate alternatives to combined treatment with barbiturates and teniposide due to likely for reduced teniposide concentrations.
butabarbital will reduce the extent or effect of triamcinolone acetonide injectable suspension by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
butabarbital and olopatadine intranasal the two boost sedation. Avoid or Use Alternate Drug. Coadministration increases risk of CNS melancholy, which can result in additive impairment of psychomotor general performance and cause daytime impairment.
butabarbital will reduce the extent or impact of conjugated estrogens by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.